Official publication of Rawalpindi Medical University
CHILDREN ON ANTI EPILEPTIC DRUGS HAVE LOW SERUM CALCIUM AND RAISED ALKALINE PHOSPHATASE LEVELS

Supplementary Files

PDF

Keywords

Epilepsy, Antiepileptic Drugs, Hypocalcemia, Alkaline Phosphatase Levels.

How to Cite

1.
Rani T, Qudrat SM, Aziz S, Um Min Allah N, Khalid A, Tabassum M. CHILDREN ON ANTI EPILEPTIC DRUGS HAVE LOW SERUM CALCIUM AND RAISED ALKALINE PHOSPHATASE LEVELS. JRMC [Internet]. 2023 Apr. 2 [cited 2024 May 26];27(1). Available from: http://www.journalrmc.com/index.php/JRMC/article/view/1614

Abstract

Objective: Epilepsy is a common neurological disorder in children requiring long-term therapy using anti-epileptic drugs (AEDs). Chronic use of AEDs may impair bone health. This study aimed to determine the biochemical changes affecting bone metabolism in pediatric epileptic patients taking AEDs. 

Materials and Methods: This cross-sectional study was conducted in the Department of Pediatrics of Benazir Bhutto Hospital, Rawalpindi from January 2019 to July 2019. A total of 95 children were enrolled based on non-probability consecutive sampling technique. Bone metabolism was evaluated by measuring serum calcium and alkaline phosphatase levels in all the study participants. Data was entered on SPSS v 22 and descriptive statistics were applied. 

Results: Of 95 epileptic children, 50.53% (n=48) were male and 49.47% (n=47) were females taking AEDs (either carbamazepine, valproate sodium or phenobarbital), 47.37% (n=45) were between 2-6 years of age while 52.63% (n=50) were between 7-11 years of age (Mean age: 6.53±2.54 years). Mean calcium and alkaline phosphatase levels of patients were calculated as 7.94±2.3 mg/dl and 226.31±17.45 IU/L respectively. Frequency of hypocalcemia in patients taking AEDs was recorded in 67.37% (n=64) and 81.05% (n=77) had raised alkaline phosphatase levels. 

Conclusion: This study concludes that frequency of hypocalcemia and raised alkaline phosphatase levels in patients taking AEDs is higher and needs attention to address this issue while the magnitude recorded in this study is primary in local population which needs to be re-assessed through multi-center trials.  

https://doi.org/10.37939/jrmc.v27i1.1614

References

Rho JM, Boison D. The metabolic basis of epilepsy. Nat Rev Neurol. 2022;18(6):333-347. doi: 10.1038/s41582-022-00651-8.

Khalid H, Arif S, Hashmat A, Arif S, Farrukh H. An Analysis of breakthrough seizures and related factors in pediatric epilepsy patients. J Pak Med Assoc. 2022;72(2):280–3.

Ullah S, Ali N, Khan A, Ali S, Nazish HR. The Epidemiological Characteristics of Epilepsy in the Province of Khyber Pakhtunkhwa, Pakistan. Front Neurol. 2018;9:845. doi: 10.3389/fneur.2018.00845.

Fricke-Galindo I, Jung-Cook H, LLerena A, López-López M. Pharmacogenetics of adverse reactions to antiepileptic drugs. Neurología. 2018;33(3):165–76.

Fahmy EM, Rashed LA, Ismail RS, Helmy H, Mekkawy DA. Evaluation of bone health among epileptic patients using biochemical markers and DEXA scan: an Egyptian study. Egypt J Neurol Psychiatr Neurosurg. 2018;54(1):10. doi: 10.1186/s41983-018-0014-2.

Menon B, Mehndiratta MM. Bone health in epilepsy. Int J Epilepsy. 2017;4(1):59–64.

Ko A, Kong J, Samadov F, Mukhamedov A, Kim YM, Lee Y-J, et al. Bone health in pediatric patients with neurological disorders. Ann Pediatr Endocrinol Metab. 2020;25(1):15–23.

Lee H-S, Wang S-Y, Salter DM, Wang C-C, Chen S-J, Fan H-C. The impact of the use of antiepileptic drugs on the growth of children. BMC Pediatr. 2013;13(1):1–7.

Rocha S, Ferraz R, Prudêncio C, Fernandes MH, Costa‐Rodrigues J. Differential effects of antiepileptic drugs on human bone cells. J Cell Physiol. 2019;234(11):19691–701.

Pitetzis DA, Spilioti MG, Yovos JG, Yavropoulou MP. The effect of VPA on bone: From clinical studies to cell cultures—The molecular mechanisms revisited. Seizure. 2017;48:36–43. doi: 10.1016/j.seizure.2017.03.013.

Arora E, Singh H, Gupta YK. Impact of antiepileptic drugs on bone health: Need for monitoring, treatment, and prevention strategies. J Family Med Prim Care. 2016;5(2):248–53.

Nakhaee Moghadam M, Teimouri A, Khajeh A, Hoseini SB. Bone metabolism disorder in epileptic children. Iran J Child Neurol. 2018;12(2):17–24.

Fan H-C, Lee H-S, Chang K-P, Lee Y-Y, Lai H-C, Hung P-L, et al. The impact of anti-epileptic drugs on growth and bone metabolism. Int J Mol Sci. 2016;17(8):1242.

Meier C, Kraenzlin ME. Antiepileptics and bone health. Ther Adv Musculoskelet Dis. 2011;3(5):235–43.

Zhang Y, Zheng Y, Zhu J, Zhang J, Zheng Z. Effects of antiepileptic drugs on bone mineral density and bone metabolism in children: A meta-analysis. J Zhejiang Univ Sci B. 2015;16(7):611–21. Available from: https://doi.org/10.1631/jzus.B1500021

Paticheep S, Chotipanich C, Khusiwilai K, Wichaporn A, Khongsaengdao S. Antiepileptic drugs and bone health in Thai children with epilepsy. J Med Assoc Thai. 2015;98(6):535–41.

Osman NMM, Abdel Aziz RA, Soliman GT, Gamal Mohamed A. Bone mineral density evaluation o epileptic children on anti-epileptic medications. Egypt J Radiol Nucl Med. 2017;48(4):1083–90. Available from: https://doi.org/10.1016/j.ejrnm.2017.07.006

Inaloo S, Forough S, Paktinat M, Katibeh P, Nemati H, Omrani GR. Evaluation of The Metabolic Syndrome Criteria And Body Composition in Ambulatory Children with Epilepsy UsingSodium Valproate and Carbamazepine In Southern Iran: A Case-Control Study. Iran J Child Neurol. 2020;14(3):47.

Babayigit A, Dirik E, Bober E, Cakmakcı H. Adverse effects of antiepileptic drugs on bone mineral density. Pediatr Neurol. 2006;35(3):177–81.

Siniscalchi A, Murphy S, Cione E, Piro L, de Sarro G, Gallelli L. Antiepileptic drugs and bone health: current concepts. Psychopharmacol Bull. 2020;50(2):36.

Chaudhuri JR, Mridula KR, Rathnakishore C, Balaraju B, Bandaru VS. Association of 25-hydroxyvitamin D deficiency in pediatric epileptic patients. Iran J Child Neurol. 2017;11(2):48.

Hasaneen B, Elsayed RM, Salem N, Elsharkawy A, Tharwat N, Fathy K, et al. Bone mineral status in children with epilepsy: biochemical and radiologic markers. J Pediatr Neurosci. 2017;12(2):138.

Erbayat Altay E, Serdaroğlu A, Tümer L, Gücüyener K, Hasanoğlu A. Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab. 2000;13(7):933–9.

Ajmal RS, Sengar GS, Keerti G. Effect of Ionic Calcium and Vitamin D3 in Lumbar Spine Bone Mineral Density of Paediatric Epileptic Patients on Antiepileptic Drugs. J Clin Diagn Res. 2022;16(8):5-8

Vijayakumar M, BK A, George B, Bhatia V. Vitamin D Status in Children on Anticonvulsant Therapy. Indian J Pediatr [Internet]. 2022;89(6):541–5. Available from: https://doi.org/10.1007/s12098-021-03853-y

Saket S, Varasteh N, Asl AAH, Saneifard H. How antiepileptics may change the serum level of vitamin D, calcium, and phosphorus in children with epilepsy. Iran J Child Neurol. 2021;15(1):19.

Tekin E, Gül ÜŞ, Aydın SK, Köksoy AY. Evaluation of Bone Metabolism in Children Using Antiseizure Drugs: A Single-Center Experience and Review of the Literature. J Pediatr Epilepsy. 2022;11(04):103–10. Available from: http://www.thieme-connect.com/products/ejournals/html/10.1055/s-0042-1749343

Pack AM. The association between antiepileptic drugs and bone disease. Epilepsy Curr. 2003;3(3):91–5.

Krishnamoorthy G, Karande S, Ahire N, Mathew L, Kulkarni M. Bone metabolism alteration on antiepileptic drug therapy. Indian J Pediatr. 2009;76(4):377–83.

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyright (c) 2023 Tanzeela Rani, Syeda Mammona Qudrat, Salma Aziz, Ammara Khalid, Mobeen Tabassum, Prof. Rai Muhammad Asghar